Reducing Opioid Risk Act
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2018-03-22 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate |
| 2018-03-22 | IntroReferral | Introduced in Senate | Library of Congress |